MedTrace Logo

TAP Block With Two Different Doses of Levobupivacaine

NCT02567487 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-10-05

No results posted yet for this study

Summary

The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery.

The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Levobupivacaine

Transversus abdominis plane block with levobupivacaine

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Neslihan Alkis · Ankara University Medical Faculty

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-01-31
Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567487 on ClinicalTrials.gov